Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03623074 · ClinicalTrials.gov registry record · NA
Control of Myopia Using Novel Spectacle Lens Designs
A NA study of Juvenile Myopia, sponsored by SightGlass Vision.
- Active
- Registry status
- NA
- Development phase
- 266
- Enrollment target
- 14
- Study locations
NCT03623074: Active NA study of Juvenile Myopia, sponsored by SightGlass Vision.
NCT03623074 is a NA study of Juvenile Myopia that is active but no longer recruiting, run by SightGlass Vision. The registered enrollment target is 266 participants, above the 94-participant average among 6 other Juvenile Myopia trials with a reported enrollment target (183% higher). The trial reports 14 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03623074, a NA study of Juvenile Myopia, is active but no longer recruiting, sponsored by SightGlass Vision.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 266 participants
- Enrollment target
- 14
- Study locations
Study Summary
Randomized, controlled, multisite, subject-and observer-masked, 3-arm parallel group clinical trial of 36-month duration to evaluate the safety and efficacy of a novel spectacle lens design in reducing the progression of juvenile myopia.
Primary Outcome
Change in axial length from baseline
Conditions Studied
Interventions
- DEVICE Novel spectacle lens design
- DEVICE Spectacle lenses
Study Locations (14)
New York
- SUNY School of Optometry - New York
- Sacco Eye Group - Vestal
- Dept of Clinical Research, South Shore Eye Care, LLP - Wantagh
Florida
- Sabal Eye Care - Longwood
- Visual Performance Center - Pensacola
California
- Golden Optometric Group - Whittier
Kansas
- Kannarr Eye Care - Pittsburg
Louisiana
- Eye Associates of Northeast Louisiana (DBA Haik Humble Eye Center) Research Dept - West Monroe
Missouri
- Advanced Eyecare, PC - Raytown
South Dakota
- Dunes Eye Consultants - Dakota Dunes
Tennessee
- Total Eye Care - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 266 participants |
| Start Date | 2018-07-16 |
| Est. Completion | 2026-03-31 |
| Phase | NA |
What the registry record for NCT03623074 still lists
NCT03623074 is an interventional study that assigns participants to a tested intervention. The registered 266 participants enrollment target is mid-sized for trials with a published cap, above the 94-participant average among 6 other Juvenile Myopia trials with a reported enrollment target (183% higher).
The record links to 1 condition, with Juvenile Myopia appearing as the primary indexed condition, and to 2 interventions - of which Novel spectacle lens design is the first listed.
NCT03623074 lists 14 locations in 11 states (New York, Florida, California).
Frequently Asked Questions
What is clinical trial NCT03623074 about?
NCT03623074 is a clinical study titled "Control of Myopia Using Novel Spectacle Lens Designs". Randomized, controlled, multisite, subject-and observer-masked, 3-arm parallel group clinical trial of 36-month duration to evaluate the safety and efficacy of a novel spectacle lens design in reducing the progression of juvenile myopia.
What is the current status of trial NCT03623074?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 266 participants. The study started on 2018-07-16. Estimated completion is 2026-03-31.
What conditions does trial NCT03623074 study?
This clinical trial studies the following conditions: Juvenile Myopia.
What interventions are being tested in trial NCT03623074?
The interventions under investigation include: Novel spectacle lens design (DEVICE), Spectacle lenses (DEVICE).
Who is sponsoring clinical trial NCT03623074?
This trial is sponsored by SightGlass Vision, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03623074 being conducted?
This trial has 14 study locations across California, Florida, Kansas, Louisiana, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Juvenile Myopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Children's Viewing Behavior
RECRUITING · NA
-
Efficacy in Controlling Myopia in Young Children Using a Novel Spectacle Lens
RECRUITING · NA
-
CYPRESS Efficacy and Safety Study Extension
ACTIVE NOT RECRUITING · NA
-
Myopia Control Spectacle Lens Cessation Study
ACTIVE NOT RECRUITING · NA
-
Spectacle Lens Visual Acuity Assessments Study
ACTIVE NOT RECRUITING · NA
-
Myopia Assessment of Two Manufacturing Processes
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05098652 · 266 participants · NA
Coaching Dementia Caregivers to Master Care-Resistant Behavior
- NCT06088277 · 266 participants · NA
Texting to Reduce Human Immunodeficiency Virus (HIV) Risk
- NCT06261814 · 266 participants · Phase 2
Contrast Enhanced Ultrasound to Evaluate Response to Chemoembolization in Patients With Liver Tumors
- NCT06312124 · 266 participants · NA
A Study of Opportunistic Salpingectomy to Prevent Ovarian Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI